Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids

NCT01601821 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

245

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation

Interventions

DRUG: CsA+Rapamune+CS
DRUG: CsA+MMF+CS

Sponsor

Pfizer